Nitzan Atia

Researcher
Sheba Medical Center
Tel Hashomer, Tel Aviv, Israel

Presentation(s):

• OC 43.5 - Should immune tolerance be pursued in the era of Emicizumab? Longitudinal follow up of a FVIII inhibitor cohort - Real World Data

  Monday, June 26, 2023
  15:45 – 16:00 ET